UCSF

ZINC03830990

Substance Information

In ZINC since Heavy atoms Benign functionality
September 30th, 2005 12 Yes

Other Names:

(+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-; 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (+-)-; C8H14N2O2; Etiracetam; Etiracetam [INN]; Etiracetamum [INN-Latin]; Keppra; LS-137052; UCB 6474; UCB-6474; alpha-e

(-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide

(2S)-2-(2-oxopyrrolidin-1-yl)butanamide

(R)-2-(2-Oxo-pyrrolidin-1-yl)-butyramide

(R)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (R)-; C8H14N2O2; LS-137053; UCB-L 060; etiracetam, R-isomer

(S)-2-(2-Oxopyrrolidin-1-yl)butanamide

(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide

racetam

1-Pyrrolidineacetamide, .alpha.-ethyl-2-oxo-, (.alpha.S)-

1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-

1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (S)-

102767-28-2

102767-28-2; C07841; Levetiracetam

102767-28-2; D00709; E keppra (TN); Keppra (TN); Levetiracetam (JAN/USAN/INN)

2-(2-oxopyrrolidin-1-yl)butanamide

AC-1479

AC1NR4PY

BIDD:GT0242

C8H14N2O2

CHEMBL1286

CID5284583

CPD000466303

DAP000502

Etiracetam

Etiracetam (INN)

Etiracetam levo-isomer

etiracetam, S-isomer

FT-0082600

HMS2051D07

HMS2089L20

Keppra

Keppra XR

Keppra, Keppra XR),Levetiracetam

L-059

Levetiracetam [INN]

Levetiracetam [INN];Levetiracetamum [INN-Latin];Levitiracetam

Levetiracetamum [INN-Latin]

Levetiractam

Leviteracetam

Levitiracetam

LS-137054

MFCD00867782

MFCD00868507

MFCD03265610

MLS000759403

MLS001424069

MolPort-003-848-377

NA

NCGC00186028-01

S1356_Selleck

SAM001246539

SBB070161

SIB-S1

SMR000466303

TL8000131

Torleva

ucb L060

UCB-22059

UCB-6474

UCB-L 059

UCB-L 060

UCB-L059

ZINC01547851

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 0.23 2 -16.44 2 4 0 63 170.212 3

Vendor Notes

Note Type Comments Provided By
biological_use Anticonvulsant ZereneX Building Blocks
ALOGPS_SOLUBILITY 2.98e+02 g/l DrugBank-approved
biological_use Anticonvulsant IBScreen Bioactives IBScreen Bioactives
mechanism Nootropic (cognition enhancer) ZereneX Building Blocks
biological_use Used to treat epilepsy IBScreen Bioactives

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )